CXCL8 and systemic sclerosis: Utilizing specific receptor antagonists, we analyzed whether the observed IL-8 and CCL18 responses of PBMCs induced by SSc-IgGs (Figures 4D and 4E) were mediated through AT1R and/or ETAR.